Dable Habib J
Insider CIK 1690773 · XLRN CEO and President, Director · ALBO Director · MLND Director · BPMC Director · SGP Director · AVTE Director · RLAY Director · PEPG Director · DAWN Director · TYRA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PEPG PepGen Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 32,947 | — | $0 | 32,947 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 22,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 66,660 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 15,000 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 44,400 | — | $0 | 44,400 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | A Award deriv | 2026-02-05 | 2026-02-09 | 27,400 | — | $0 | 27,400 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 66,660 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 66,660 | — | $0 | 66,660 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 32,335 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 207,931 | — | $0 | 207,931 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,950 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 8,742 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 8,742 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 12,644 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 8,742 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-05-23 | 2024-05-28 | 32,335 | — | $0 | 32,335 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-03-04 | 2024-03-06 | 1,531 | $16.37 | $25.1K | 1,531 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-17 | 2024-01-19 | 66,660 | — | $0 | 66,660 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-01-02 | 2024-01-04 | 2,964 | $13.49 | $40.0K | 2,964 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-07-10 | 2023-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 6,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 16,000 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2022-10-03 | 2022-10-03 | 22,686 | — | $0 | 22,686 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2022-08-08 | 2022-08-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-23 | 2022-06-27 | 7,950 | — | $0 | 7,950 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-23 | 2022-06-27 | 3,900 | — | $0 | 3,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 84,720 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 64,361 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 106,400 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 108,800 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 250,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 98,450 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-07-02 | 2021-07-02 | 42,186 | — | $0 | 250,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-07-02 | 2021-07-02 | 42,186 | $35.04 | $1.48M | 140,636 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-02 | 2021-07-02 | 29,140 | $126.69 | $3.69M | 111,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-02 | 2021-07-02 | 11,458 | $127.51 | $1.46M | 100,038 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-02 | 2021-07-02 | 1,588 | $128.21 | $203.6K | 98,450 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-07-01 | 2021-07-02 | 57,814 | — | $0 | 292,186 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-07-01 | 2021-07-02 | 57,814 | $35.04 | $2.03M | 156,264 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-01 | 2021-07-02 | 9,194 | $125.81 | $1.16M | 135,225 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-01 | 2021-07-02 | 23,160 | $126.85 | $2.94M | 112,065 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-01 | 2021-07-02 | 4,560 | $127.89 | $583.2K | 107,505 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-01 | 2021-07-02 | 9,055 | $128.82 | $1.17M | 98,450 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-07-01 | 2021-07-02 | 11,845 | $125.15 | $1.48M | 144,419 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 64,361 | — | $0 | 64,361 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 16,662 | — | $0 | 98,450 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 94 | $122.55 | $11.5K | 81,788 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 764 | $122.46 | $93.6K | 81,882 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 900 | $121.55 | $109.4K | 82,646 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 2,500 | $120.52 | $301.3K | 83,546 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2021-01-04 | 2021-01-06 | 3,278 | $124.31 | $407.5K | 86,046 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-07-01 | 2020-07-06 | 50,000 | — | $0 | 350,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 3,700 | $93.53 | $346.1K | 135,624 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-07-01 | 2020-07-06 | 50,000 | $35.04 | $1.75M | 139,324 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 3,000 | $94.46 | $283.4K | 132,624 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 13,047 | $95.85 | $1.25M | 119,577 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 15,219 | $96.49 | $1.47M | 104,358 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 9,534 | $97.43 | $928.9K | 94,824 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 4,400 | $98.57 | $433.7K | 90,424 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-01 | 2020-07-06 | 1,100 | $99.42 | $109.4K | 89,324 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-06-22 | 2020-06-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 84,720 | — | $0 | 84,720 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 22,173 | — | $0 | 89,324 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-03 | 2020-01-03 | 3,634 | $51.24 | $186.2K | 67,151 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-03 | 2020-01-03 | 98 | $51.26 | $5.0K | 70,785 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 344 | $45.67 | $15.7K | 70,883 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 5,281 | $45.20 | $238.7K | 71,227 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-06-20 | 2019-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 146 | $44.23 | $6.5K | 76,508 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 7,214 | $44.60 | $321.7K | 76,754 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 100 | $45.46 | $4.5K | 76,654 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 106,400 | — | $0 | 106,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 17,700 | — | $0 | 83,968 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-01-15 | 2019-01-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-03 | 2019-01-04 | 27 | $40.85 | $1.1K | 66,268 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-03 | 2019-01-04 | 1,930 | $43.45 | $83.9K | 66,295 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2018-12-07 | 2018-12-11 | 14,880 | — | $0 | 14,880 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-12-04 | 2018-12-06 | 2,506 | $51.54 | $129.2K | 78,394 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-12-04 | 2018-12-06 | 3,862 | $52.72 | $203.6K | 74,532 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-12-04 | 2018-12-06 | 5,607 | $53.65 | $300.8K | 68,925 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-12-04 | 2018-12-06 | 700 | $54.33 | $38.0K | 68,225 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 108,800 | — | $0 | 108,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 18,100 | — | $0 | 80,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-12-01 | 2016-12-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2016-12-01 | 2016-12-05 | 62,800 | — | $0 | 62,800 | SEC↗ |